Management of Merkel tumours: an evidence-based review
- PMID: 18391627
- DOI: 10.1097/CCO.0b013e3282fe6ad8
Management of Merkel tumours: an evidence-based review
Abstract
(1) Merkel cell carcinoma (MCC) is a rare, aggressive skin cancer of neuroendocrine origin generally seen in patients over 50 years of age. It has a high propensity for recurrence post-treatment; 5-year overall survival rates range from 23% to 80%. (2) The rarity of MCC means that there is a lack of prospective controlled trials in these patients. Patients are generally treated with surgery as a first-line therapy, supplemented with adjuvant radiotherapy and chemotherapy if required. (3) The use of adjuvant therapies in MCC remains controversial. Data from case series and meta-analyses of case series suggest that the addition of radiotherapy to surgery in patients with MCC can confer significant benefits with regard to reducing local and regional recurrence rates and prolonging disease-free survival. Generally, the current literature tends not to support the use of chemotherapy in these patients. (4) Stage-specific treatment regimens have been outlined involving various combinations of surgery, radiation and chemotherapy for International Union Against Cancer (UICC) stage I to III disease, while the emphasis of treatment in patients with UICC stage IV disease is on palliative care with or without radio- or chemotherapy. There is a need for more structured clinical research to better illuminate the most effective treatments for this disease.
Similar articles
-
Merkel cell carcinoma: report of 10 cases and review of the literature.J Am Acad Dermatol. 2000 Nov;43(5 Pt 1):755-67. doi: 10.1067/mjd.2000.106505. J Am Acad Dermatol. 2000. PMID: 11050578 Review.
-
Merkel cell carcinoma: improved outcome with adjuvant radiotherapy.ANZ J Surg. 2005 May;75(5):275-81. doi: 10.1111/j.1445-2197.2005.03353.x. ANZ J Surg. 2005. PMID: 15932436
-
Adjuvant local irradiation for Merkel cell carcinoma.Arch Dermatol. 2006 Jun;142(6):693-700. doi: 10.1001/archderm.142.6.693. Arch Dermatol. 2006. PMID: 16785371
-
Radiotherapy for localised and advanced Merkel cell carcinoma of the skin: a single institution case series.Eur J Dermatol. 2007 May-Jun;17(3):229-33. doi: 10.1684/ejd.2007.0154. Epub 2007 May 4. Eur J Dermatol. 2007. PMID: 17478386
-
Merkel cell carcinoma: clinicopathological aspects of an unusual neoplasm.J BUON. 2007 Apr-Jun;12(2):173-9. J BUON. 2007. PMID: 17600868 Review.
Cited by
-
Merkel cell carcinoma: chemotherapy and emerging new therapeutic options.J Skin Cancer. 2013;2013:327150. doi: 10.1155/2013/327150. Epub 2013 Feb 10. J Skin Cancer. 2013. PMID: 23476782 Free PMC article.
-
Clinical features and treatment of vulvar Merkel cell carcinoma: a systematic review.Gynecol Oncol Res Pract. 2017 Jan 25;4:2. doi: 10.1186/s40661-017-0037-x. eCollection 2017. Gynecol Oncol Res Pract. 2017. PMID: 28138393 Free PMC article. Review.
-
Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-I.Cancer Immunol Res. 2014 Jan;2(1):27-36. doi: 10.1158/2326-6066.CIR-13-0087. Cancer Immunol Res. 2014. PMID: 24432305 Free PMC article.
-
Multimodality management for 145 cases of Merkel cell carcinoma.Med Oncol. 2010 Dec;27(4):1260-6. doi: 10.1007/s12032-009-9369-7. Epub 2009 Dec 1. Med Oncol. 2010. PMID: 19949898
-
Merkel cell carcinoma: an illustrative case and review.Postepy Dermatol Alergol. 2014 Oct;31(5):325-8. doi: 10.5114/pdia.2014.40797. Epub 2014 Oct 22. Postepy Dermatol Alergol. 2014. PMID: 25395930 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical